{
  "title": "Fluvoxamine for Treating COVID-19",
  "itunes:title": "Fluvoxamine for Treating COVID-19",
  "pubDate": "Fri, 07 Jan 2022 17:00:00 +0000",
  "guid": "77d84d8b-4f9b-42e6-b84e-f8782cca337a",
  "link": "https://psychopharmacology.libsyn.com/fluvoxamine-for-treating-covid-19",
  "itunes:image": "",
  "description": "<p>How effective is fluvoxamine in patients with COVID-19? A 2-week course of full-dose fluvoxamine decreased clinical deterioration in outpatients with symptomatic COVID-19 infection.</p> <p>Faculty: Jim Phelps, M.D.<br /> Hosts: Jessica Diaz, M.D.; Lorena Rodríguez, M.D.</p> <ul> <li><strong><a href= \"https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC133\"> Learn more about our memberships here</a></strong></li> <li><a href= \"https://psychopharmacologyinstitute.com/publication/quick-take-vol-30-2604?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC133\"> <strong>Earn 0.5 CMEs: Quick Take Vol. 30</strong></a></li> <li><a href= \"https://psychopharmacologyinstitute.com/section/fluvoxamine-vs-placebo-and-clinical-deterioration-in-outpatients-with-symptomatic-covid-19-2604-5082?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC133\"> <strong>Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19</strong></a></li> </ul>",
  "content:encoded": "<p>How effective is fluvoxamine in patients with COVID-19? A 2-week course of full-dose fluvoxamine decreased clinical deterioration in outpatients with symptomatic COVID-19 infection.</p> <p>Faculty: Jim Phelps, M.D. Hosts: Jessica Diaz, M.D.; Lorena Rodríguez, M.D.</p> <ul> <li><a href= \"https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC133\"> Learn more about our memberships here</a></li> <li><a href= \"https://psychopharmacologyinstitute.com/publication/quick-take-vol-30-2604?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC133\"> Earn 0.5 CMEs: Quick Take Vol. 30</a></li> <li><a href= \"https://psychopharmacologyinstitute.com/section/fluvoxamine-vs-placebo-and-clinical-deterioration-in-outpatients-with-symptomatic-covid-19-2604-5082?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC133\"> Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19</a></li> </ul>",
  "enclosure": "",
  "itunes:duration": "09:40",
  "itunes:explicit": false,
  "itunes:keywords": "",
  "itunes:subtitle": "How effective is fluvoxamine in patients with COVID-19? A 2-week course of full-dose fluvoxamine decreased clinical deterioration in outpatients with symptomatic COVID-19 infection. Faculty: Jim Phelps, M.D. Hosts: Jessica Diaz, M.D.; Lorena...",
  "itunes:episodeType": "full"
}